Takaisin Tulosta

Hoidon tavoitteet: perustelut tehokkaalle LDL-kolesterolitason pienentämiselle

Lisätietoa aiheesta
Timo Strandberg


  1. De Backer G, Ambrosioni E, Borch-Jonsen K ym. Eurooppalainen suositus: Sydän- ja verisuonitautien ehkäisy käytännön lääkärin työssä. Suom Lääkäril 2004;59:2120-8
  2. De Backer G, Ambrosioni E, Borch-Johnsen K ym. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10 «PMID: 12964575»PubMed
  3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97 «PMID: 11368702»PubMed
  4. Suomalaisen Lääkäriseuran Duodecimin, Suomen Sisätautilääkäreiden yhdistyksen ja Diabetesliiton lääkärineuvoston asettama työryhmä. Diabetes. Käypä hoito -suositus (online http://www.kaypahoito.fi)
  5. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002;324:1570-6 «PMID: 12089098»PubMed
  6. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med 1997;336:153-62 «PMID: 8992351»PubMed
  7. Schartl M, Bocksch W, Koschyk DH ym. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001;104:387-92 «PMID: 11468198»PubMed
  8. Pitt B, Waters D, Brown WV ym. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999;341:70-6 «PMID: 10395630»PubMed
  9. Schwartz GG, Olsson AG, Ezekowitz MD ym. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-8 «PMID: 11277825»PubMed
  10. Nissen SE, Tuzcu EM, Schoenhagen P ym. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-80 «PMID: 14996776»PubMed
  11. Crouse JR 3rd, Raichlen JS, Riley WA ym. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007;297:1344-53 «PMID: 17384434»PubMed
  12. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22 «PMID: 12114036»PubMed
  13. Leeper NJ, Ardehali R, deGoma EM ym. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival. Circulation 2007;116:613-8 «PMID: 17664373»PubMed
  14. Cannon CP, Blazing MA, Giugliano RP ym. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med 2015;372:2387-97 «PMID: 26039521»PubMed
  15. Sabatine MS, Giugliano RP, Keech AC ym. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med 2017;376:1713-1722 «PMID: 28304224»PubMed